Connect with us
The U.S. Supreme Court ruled that district courts cannot reinstate NIH-canceled grants but can review the legality of Trump-era guidelines restricting DEI, gender identity, and COVID-19...
The Virgen del Rocío University Hospital, University of Seville, and Pablo de Olavide University launched an AI-driven project to identify sarcoma biomarkers. Using high-performance computing, the...
Researchers at Massachusetts General Hospital found that clusterin, a protein with stage-dependent effects, can protect neurons by reducing inflammation and preserving synapses, complementing anti-amyloid therapies. However,...
China has overtaken the U.S. in new pharmaceutical innovation after leading the world in new drug discoveries in 2024, with 28 new molecules discovered. Although it...
SunRock Biopharma, a Galician biotech firm, develops next-generation antibody-based drugs targeting resistant cancers and immune diseases. Founded by Laureano Simón, it focuses on early clinical phases...
Castile and León’s Health Ministry launched its 2025–2030 Strategy for Advanced Therapies to boost innovation in biotech and regenerative medicine. Key goals include doubling clinical trials,...
A CNIC-led study published in Nature identifies imidazole propionate (ImP), a gut-derived metabolite, as a blood biomarker and causal agent of early atherosclerosis. ImP activates systemic...
Sarcomas are rare malignant tumors of connective tissue, representing a small cancer percentage but posing major treatment challenges. Advanced biotechnology, especially CAR-T immunotherapies, offers hope. CIBERONC...
Spain’s Ministry of Science has awarded €126.9M in subsidies to companies in the EU-backed IPCEI Med4Cure project. The initiative supports healthcare innovation, advanced therapies, and sustainable...
The €196.4 million Biotech Booster fund in the Netherlands supports scientists and research teams to turn biotech innovations into market-ready solutions. Funded by the National Growth...
 |
|
 |  |
 |
|